These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 436143)
1. [Treating gout with benzbromarone (author's transl)]. Bosmanský K; Trnavský K Cas Lek Cesk; 1979 Feb; 118(5):153-6. PubMed ID: 436143 [No Abstract] [Full Text] [Related]
2. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)]. Mertz DP Dtsch Med Wochenschr; 1976 Aug; 101(35):1288-92. PubMed ID: 782809 [No Abstract] [Full Text] [Related]
3. [Long-term therapy with benzbromarone in uric arthritis]. Bröll H; Sochor H; Tausch G; Eberl R Wien Med Wochenschr; 1975 Sep; 125(28):546-8. PubMed ID: 816095 [No Abstract] [Full Text] [Related]
4. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)]. Matzkies F; Berg G Dtsch Med Wochenschr; 1976 Oct; 101(43):1568-70. PubMed ID: 991731 [TBL] [Abstract][Full Text] [Related]
5. [Benzbromarone in the treatment of gout]. Kawenoki-Minc E; Brzozowska-Jurkowska AM Reumatologia; 1980; 18(1):61-7. PubMed ID: 6994191 [No Abstract] [Full Text] [Related]
6. [Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks]. Brzozowska-Jurkowska AM Reumatologia; 1980; 18(3):287-92. PubMed ID: 6999575 [No Abstract] [Full Text] [Related]
7. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)]. Mertz DP Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138 [TBL] [Abstract][Full Text] [Related]
8. [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses]. Mertz DP; Borner K Med Welt; 1983 Sep; 34(36):974-9. PubMed ID: 6633222 [No Abstract] [Full Text] [Related]
9. Ten years' experience with benzbromarone in the management of gout and hyperuricaemia. Masbernard A; Giudicelli CP S Afr Med J; 1981 May; 59(20):701-6. PubMed ID: 7221794 [TBL] [Abstract][Full Text] [Related]
10. [Allomaron in hyperuricemia and gout]. Barsom S ZFA (Stuttgart); 1979 Aug; 55(24):1336-40. PubMed ID: 539082 [No Abstract] [Full Text] [Related]
11. [Normurat (benzbromaron) in the treatment of gout]. Bosmanský K; Trnavský K Z Rheumatol; 1979; 38(9-10):342-8. PubMed ID: 525067 [TBL] [Abstract][Full Text] [Related]
12. [A new drug therapy for gout and hyperuricemia. Long term results]. Masbernard A; Giudicelli CP Sem Hop Ther; 1976; 52(7-8):369-74. PubMed ID: 996556 [No Abstract] [Full Text] [Related]
13. [The effect of benzbromaron in gout patients with limited kidney function]. Kuzmits R; Bresnik W; Müller MM Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087 [TBL] [Abstract][Full Text] [Related]
14. [Results obtained with long-term benzbromarone therapy (author's transl)]. Bresnik W; Müller MM Wien Klin Wochenschr; 1974 May; 86(10):283-7. PubMed ID: 4428763 [No Abstract] [Full Text] [Related]
19. [Indications for and methods of allopurinol-benzbromarone combination therapy in the treatment of hyperuricemic metabolic disorders]. Heidelmann G; Burck G; Dauterstedt W; Heinrich JJ; Ohlmer R Z Arztl Fortbild (Jena); 1982 Mar; 76(5):177-81. PubMed ID: 6896252 [No Abstract] [Full Text] [Related]
20. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia]. Matzkies F; Neuwirth R; Berg G Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]